Journal of Clinical Oncology, Vol 20, Issue 24
(December), 2002: 4705-4712
© 2002 American Society for Clinical Oncology
Multidisciplinary Systems Approach to Chemotherapy Safety: Rebuilding Processes and Holding the Gains
By Richard B. Womer,
Ellen Tracy,
Winson Soo-Hoo,
Betsy Bickert,
Susan DiTaranto,
Jane H. Barnsteiner
From the Department of Pediatrics and School of Nursing, University of Pennsylvania, and Division of Oncology and Departments of Pharmacy and Nursing, The Childrens Hospital of Philadelphia, Philadelphia, PA.
Address reprint requests to Richard B. Womer, MD, Division of Oncology, The Childrens Hospital of Philadelphia, 34th St and Civic Center Blvd, Philadelphia, PA 19104; email: rwomer{at}mail.med.upenn.edu
PURPOSE: The problem of medication safety came to public attention largely through a chemotherapy error, and the high toxicity and low therapeutic index of anticancer medications make safety in their prescription and administration critical. We have undertaken a thorough revision of our systems for inpatient chemotherapy.
METHODS: We participated in a multi-institutional collaborative effort of the Institute for Healthcare Improvement, and used their rapid cycle change method. Particularly powerful systems change concepts were driving out fear, "trapping" errors and learning from them, focusing on outcome rather than on input, simplifying and standardizing, using constraints and "forcing functions," reducing handoffs, and paying attention to human factors.
RESULTS: Applying these concepts to our chemotherapy delivery system, we have achieved an 84% decrease in the number of chemotherapy errors that actually reach patients per 1,000 chemotherapy doses, and have sustained that improvement for 5 years.
CONCLUSION: Factors contributing to our success include the rapid cycle change method, strong support from hospital administration, grassroots participation, and a tradition of interdisciplinary cooperation. Computerized direct physician order entry and cooperative group participation have had mixed effects. Continued efforts at improvement have been key to holding our gains. Although specific problems and changes may not be relevant to other organizations, the concepts and methods we used are generally applicable.

CiteULike Complore Connotea Del.icio.us Digg Facebook Reddit Technorati Twitter What's this?
Related Correspondence
- The Vincotube System: A Design Solution to Prevent the Accidental Administration of Intrathecal Vinca Alkaloids
Carlo Palmieri, Neil Barron, and David M. Vigushin
JCO 2004 22: 965
[Full Text]
Related Reply
- In Reply:
Angelou Stefanou and Michael Dooley
JCO 2004 22: 965-966
[Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
J. O. Jacobson, M. Polovich, K. K. McNiff, K. B. LeFebvre, C. Cummings, M. Galioto, K. R. Bonelli, and M. R. McCorkle
American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards
J. Clin. Oncol.,
November 10, 2009;
27(32):
5469 - 5475.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P J Newton, E J Halcomb, P M Davidson, and A R Denniss
Barriers and facilitators to the implementation of the collaborative method: reflections from a single site
Qual. Saf. Health Care,
December 1, 2007;
16(6):
409 - 414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D Parsad and M. J Ratain
Prescribing oral chemotherapy
BMJ,
February 24, 2007;
334(7590):
376 - 376.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Ford, J. Killebrew, P. Fugitt, J. Jacobsen, and E. M. Prystas
Study of Medication Errors on a Community Hospital Oncology Ward
J. Oncol. Pract,
July 1, 2006;
2(4):
149 - 154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Legant
Oncologists and Medical Malpractice
J. Oncol. Pract,
July 1, 2006;
2(4):
164 - 169.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J Gilbar and C. V Carrington
The incidence of extravasation of vinca alkaloids supplied in syringes or mini-bags
Journal of Oncology Pharmacy Practice,
June 1, 2006;
12(2):
113 - 118.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Dumasia, E. Harris, and A. Drelichman
Quality Performance Improvement With the Implementation of Standard Chemotherapy Order Forms
J. Oncol. Pract,
May 1, 2006;
2(3):
104 - 107.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. R. Kim, A. R. Chen, R. J. Arceci, S. H. Mitchell, K. M. Kokoszka, D. Daniel, and C. U. Lehmann
Error Reduction in Pediatric Chemotherapy: Computerized Order Entry and Failure Modes and Effects Analysis
Arch Pediatr Adolesc Med,
May 1, 2006;
160(5):
495 - 498.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C M van Tilburg, I P Leistikow, C M A Rademaker, M B Bierings, and A T H van Dijk
Health care failure mode and effect analysis: a useful proactive risk analysis in a pediatric oncology ward
Qual. Saf. Health Care,
February 1, 2006;
15(1):
58 - 63.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Birner, M. K. Bedell, J. T. Avery, and M. S. Ernstoff
Program to Support Safe Administration of Oral Chemotherapy
J. Oncol. Pract,
January 1, 2006;
2(1):
5 - 6.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Fabia, E. C. Rodrigo, A. A. Mari, D. A. Cubells, and N V. Jimenez Torres
Pharmaceutical validation as a process of improving the quality of antineoplastic treatment
Journal of Oncology Pharmacy Practice,
June 1, 2005;
11(2):
45 - 50.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Gilbar, M. Dooley, and J.-a. Brien
Inadvertent intrathecal administration of vincristine: are we fulfilling our roles as oncology pharmacists?
Journal of Oncology Pharmacy Practice,
December 1, 2004;
10(4):
187 - 189.
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. France, J. Cartwright, V. Jones, V. Thompson, and J. A. Whitlock
Improving Pediatric Chemotherapy Safety Through Voluntary Incident Reporting: Lessons From the Field
Journal of Pediatric Oncology Nursing,
July 1, 2004;
21(4):
200 - 206.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Palmieri, N. Barron, and D. M. Vigushin
The Vincotube System: A Design Solution to Prevent the Accidental Administration of Intrathecal Vinca Alkaloids
J. Clin. Oncol.,
March 1, 2004;
22(5):
965 - 965.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Stefanou and M. Dooley
In Reply:
J. Clin. Oncol.,
March 1, 2004;
22(5):
965 - 966.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Scavuzzo and N. Gamba
Bridging the Gap: The Virtual Chemotherapy Unit
Journal of Pediatric Oncology Nursing,
January 1, 2004;
21(1):
27 - 32.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Stefanou and M. Dooley
Simple Method to Eliminate the Risk of Inadvertent Intrathecal Vincristine Administration
J. Clin. Oncol.,
May 15, 2003;
21(10):
2044 - 2044.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Hsia
Medicare Quality Improvement: Bad Apples or Bad Systems?
JAMA,
January 15, 2003;
289(3):
354 - 356.
[Full Text]
[PDF]
|
 |
|
|